ANA CAROLINA DA SILVA ARAÚJO REZENDE
Abstract:
Titanium is a metal of first choice for use as biomaterial. Titanium alloys of type β are the most suitable for orthopedic implants. This study aims to obtain, characterize structurally and evaluate the bioactivity properties of three types of Ti-Nb-Sn alloys: a) 61% Ti-18% Nb-11% Sn of crude fusion; B) 61% Ti-35% Nb-4% Sn with thermo mechanical treatment; C) 61% Ti-35% Nb-4% Sn with thermomechanical treatment and chemically modified surface. Materials and Methods: samples were obtained by melting in an arc furnace. After melting the Ti-35Nb-4Sn samples were subjected to reduction, treatment and ther malaging. A portion of these Ti-35Nb-4Sn samples had the surface chemically and thermally modified through NaOH, CaCl, heat and water. After this process the three samples were submitted to bioactivity assay through the Kokubo procotol. The samples were immersed in PBS during different periods (1, 3, 7 and 14 days), during this period they were kept in anoven at 36.5 ± 0.03 ° C. It was verified the formation of apatite through XRD and MEV / EDS. The experimental techniques used in the characterization were: MO, DRX, FRX, MEV, and Hardness Test. Results: Structurally the Ti-18Nb-11Sn alloys howed a structure composed of the orthorhombic martensitic phase α ", with Vickers hardness of 189,5HV, MEV images present the formation of Hydroxyapatite in 14 days after immersion in PBS, XRD analysis demonstrates peaks In 2θ = 31,8 ° referring to Hydroxyapatite. The Ti-35Nb- 4Sn alloy is formed by β phase, exhibits Vickers hard ness of 270HV, SEM images demonstrating the formation of hydroxyl apatite after 7 days confirmed by XRD. Conclusion: The Ti-18Nb-11Sn alloy, shows composed of orthorhombic martensitic phase, thus presents structural and mechanical characteristics that are not considered appropriate for implants. The bioactivity assay has shown that Ti-35Nb-4Sn alloys have a more bioactive surface treatment than the others.
